Research led by Naval Medical University's Changzheng Hospital in China reports that an off-the-shelf cell therapy built from induced pluripotent stem cells (iPSCs) loosened life-limiting skin and ...

An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialized immune cells. The discovery, published in ...

Human induced pluripotent stem cell (iPSC) technology has enabled the generation of virtually any human cell type from somatic cells obtained from healthy or disease donors. This powerful platform has ...

In the study, "An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis," published in Cell, researchers engineered an allogeneic cell therapy, QN-139b, to deplete pathogenic B ...